Back to search

Denmark· DK-28101304187

Kaliumklorid "B.Braun"

A potassium chloride product containing kaliumchlorid, registered in Denmark by B. Braun Melsungen. The same ATC class is registered in 11 of our 19 countries.

ATC B05XA01

Checked against Danish Medicines Agency (Denmark) on

Informational only — not a medical device.

SOURCE REGISTER · DKDanish Medicines Agency (Denmark)normalisedKaliumklorid "B.Braun"ATCB05XA01REGISTER NO.DK-28101304187PACKS LISTED1CHECKEDSeptember 30, 2026

Where it is registered

Potassium chloride is registered in 11 of 19 countries.

Countries holding a registration under ATC B05XA01 (potassium chloride), each read from that country’s own register.

  • This record: Denmark, from Danish Medicines Agency (Denmark)
  • 7 of them publish a price we can compare per daily dose

Potassium chloride · ATC B05XA01

11 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Danish Medicines Agency (Denmark)
Active substance
KALIUMCHLORID
Manufacturer
B. Braun Melsungen
Country
Denmark (DK)
ATC code
B05XA01
ATC class
Potassium chloride
Reimbursed
Not published by this register
Source register
Danish Medicines Agency (Denmark)
Last checked
September 30, 2026

Packs & prices · 1

  • dk_varenummer
    28101304187

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

726 interactions on record for potassium chloride.

Graded by severity as the source publishes them — 108 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Potassium chloride · interactions on record

726 records

  • 108 severe
  • 26 moderate
  • 15 minor
  • 504 info

Most severe, free to view

  • DicycloverineA03AA07severe
  • PropanthelineA03AB05severe
  • MepenzolateA03AB12severe
  • TrospiumA03AB20severe

73 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Danish Medicines Agency (Denmark). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/b3ccd130-8510-4f77-95f4-20676d6e0da5
GET /v1/drugs/b3ccd130-8510-4f77-95f4-20676d6e0da5?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "koncentrat til infusionsvæske, opløsning",
  "source": "dkma",
  "strength": "1 mmol/ml",
  "auth_role": "DKMA",
  "dk_drugid": "28101304187",
  "substance": "KALIUMCHLORID",
  "auth_procedure": "National",
  "in_medicinpriser": false,
  "registration_date_serial": "32882"
}

See everything about potassium chloride.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.